Full Name
Yoshiaki Ito
Variants
Mahizhnan, A.
Ito, Y.
 
Main Affiliation
 
 
Email
csiitoy@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Department:  NATIONAL UNIVERSITY MEDICAL INSTITUTES

Results 1-20 of 61 (Search time: 0.015 seconds).

Issue DateTitleAuthor(s)
12007cDNA cloning of Runx family genes from the pufferfish (Fugu rubripes)Ng, C.E.L.; Osato, M. ; Tay, B.H.; Venkatesh, B. ; Ito, Y. 
22007CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancerLiu, Q. ; Ito, K. ; Shah, N. ; Ito, Y. ; Teh, M. ; Yeoh, K.G. 
32010Claudin-1 Has Tumor Suppressive Activity and Is a Direct Target of RUNX3 in Gastric Epithelial CellsChang, T.L. ; Ko, T.K. ; Liu, Q.; Salto-Tellez, M. ; Ito, Y. ; Ito, K. ; Yeoh, K.G. ; Fukamachi, H.
42007Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemiaAsou, N.; Mitsuya, H.; Yanagida, M.; Huang, L.; Ito, Y. ; Osato, M. ; Shigesada, K.; Yamamoto, M.
52007Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemiaAsou, N.; Mitsuya, H.; Yanagida, M.; Huang, L.; Ito, Y. ; Osato, M. ; Shigesada, K.; Yamamoto, M.
62007Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatmentHuang, C. ; Ito, K. ; Zhang, H. ; Ito, Y. ; Ida, H.
72007Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatmentHuang, C.; Ito, K. ; Zhang, H. ; Ito, Y. ; Ida, H.
82007Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.Tan, S.H.; Ida, H.; Lau, Q.C. ; Goh, B.C. ; Chieng, W.S.; Loh, M.; Ito, Y. 
92006Down-regulation of RUNX1, RUNX3 and CBFβ in hepatocellular carcinomas in an early stage of hepatocarcinogenesisMiyagawa, K.; Sakakura, C.; Nakashima, S.; Yoshikawa, T.; Kin, S.; Nakase, Y.; Yamagishi, H.; Hagiwara, A.; Ida, H.; Yazumi, S.; Ito, K. ; Chiba, T.; Ito, Y. 
102006Down-regulation of RUNX1, RUNX3 and CBFβ in hepatocellular carcinomas in an early stage of hepatocarcinogenesisMiyagawa, K.; Sakakura, C.; Nakashima, S.; Yoshikawa, T.; Kin, S.; Nakase, Y.; Yamagishi, H.; Hagiwara, A.; Ida, H.; Yazumi, S.; Ito, K. ; Chiba, T.; Ito, Y. 
112003Dual mutations in the AML1 and FLT 3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtypeMatsuno, N.; Nanri, T.; Mitsuya, H.; Asou, N.; Osato, M. ; Yamashita, N.; Yanagida, M.; Ito, Y. ; Shigesada, K.; Fukushima, T.; Motoji, T.; Kusumoto, S.; Towatari, M.; Suzuki, R.; Naoe, T.; Nishii, K.; Ohno, R.
122005Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancerSakakura, C.; Hagiwara, A.; Miyagawa, K.; Nakashima, S.; Yoshikawa, T.; Kin, S.; Nakase, Y.; Yamagishi, H.; Ito, K. ; Ito, Y. ; Yazumi, S.; Chiba, T.
132004Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell linesWada, M.; Yazumi, S.; Takaishi, S.; Hasegawa, K.; Sawada, M.; Tanaka, H.; Ida, H.; Chiba, T.; Ida, H.; Ito, K. ; Ito, Y. ; Sakakura, C.
142005Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topographyNakase, Y.; Sakakura, C.; Miyagawa, K.; Kin, S.; Fukuda, K.; Hagiwara, A.; Yamagishi, H.; Yanagisawa, A.; Koide, K.; Morofuji, M.; Hosokawa, Y.; Shimomura, K.; Katsura, K.; Ito, K. ; Ito, Y. 
152008Genetic evidence of PEBP2β-independent activation of Runx1 in the murine embryoYokomizo, T.; Honda, C.; Ema, M.; Takahashi, S.; Yamamoto, M.; Yanagida, M.; Osato, M. ; Ito, Y. ; Huang, G.
162008Genetic evidence of PEBP2β-independent activation of Runx1 in the murine embryoYokomizo, T.; Honda, C.; Ema, M.; Takahashi, S.; Yamamoto, M.; Yanagida, M.; Osato, M. ; Ito, Y. ; Huang, G.
172005Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 miceIto, Y. ; Yamashita, N.; Osato, M. ; Yanagida, M.; Shigesada, K.; Huang, L. ; Kogan, S.C.; Iwasaki, M.; Nakamura, T.; Asou, N.
182005Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 miceIto, Y. ; Yamashita, N.; Osato, M. ; Yanagida, M.; Shigesada, K.; Huang, L. ; Kogan, S.C.; Iwasaki, M.; Nakamura, T.; Asou, N.
192008Identification of marker genes including RUNX3 (AML2) that discriminate between different myeloproliferative neoplasms and normal individualsMuller, C.I.; Luong, Q.T.; Jones, L.C.; Desmond, J.C.; Kawamata, N.; Koeffler, H.P.; Shih, L.-Y.; Tcherniantchouk, O.; Liu, Q. ; Ito, K. ; Osato, M. ; Ito, Y. ; Tefferi, A.; de, Vos S.
202008In vitro differentiation of Runx3-/-p53-/-gastric epithelial cells into intestinal type cellsFukamachi, H.; Mimata, A.; Tanaka, I.; Yuasa, Y.; Ito, K. ; Ito, Y.